StockData
BioVie Inc. logo

BioVie Inc. (BIVI) stock

BIVINasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as BIVIW
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$0.94−0.05 (-5.27%)

Close on Nov 18, 2026Market cap $7.11MP/E –Yield –

BioVie total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

BioVie's total debt was $2.97M at Sep 30, 2023. For fiscal 2023 it was $5.23M, down 56.9% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2023Jun 30, 2023$5.23M-56.9%
FY2022Jun 30, 2022$12.14M+19321.9%
FY2020Jun 30, 2020$62.50K–

Quarterly total debt

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2024CQ3 2023Sep 30, 2023$2.97M-76.7%
Q4 FY2023CQ2 2023Jun 30, 2023$5.23M-56.9%
Q3 FY2023CQ1 2023Mar 31, 2023$7.41M-36.3%
Q2 FY2023CQ4 2022Dec 31, 2022$13.26M+19.3%
Q1 FY2023CQ3 2022Sep 30, 2022$12.73M+20260.7%
Q4 FY2022CQ2 2022Jun 30, 2022$12.14M+19321.9%
Q3 FY2022CQ1 2022Mar 31, 2022$11.62M+18499.9%
Q2 FY2022CQ4 2021Dec 31, 2021$11.11M+17677.9%
Q3 FY2021CQ1 2021Mar 31, 2021$62.50K–
Q2 FY2021CQ4 2020Dec 31, 2020$62.50K–
Q1 FY2021CQ3 2020Sep 30, 2020$62.50K–
Q4 FY2020CQ2 2020Jun 30, 2020$62.50K–

More BioVie figures

See a number that looks wrong?